CYMP-AS1 exerted pro-cancer effects by binding to hnRNPM, reducing the mRNA stability of AXIN2, and modulating the Wnt/β-catenin signaling pathway, ultimately accelerating the OC progression. Here, HNRNPM is linked to cancer.